Infectious Disease Alert – December 1, 2005
December 1, 2005
View Issues
-
CD4 Lymphocyte Percentage and HIV Disease Progression
This study out of Vanderbilt examined a cohort of 788 eligible patients from their clinic who received their first highly active antiretroviral therapy (HAART) regimen for at least 30 days between January 1998 and January 2003 and had a baseline CD4 lymphocyte determination in the 180 days prior to initiating antiretrovirals or within 45 of starting treatment. -
Methods for Diagnosing Intravascular Device-Related Bloodstream Infections — And the Winner Is?
There exists no consensus about the best means for diagnosing bloodstream infections related to intravascular devices (IVD), leading Safdar and colleagues to conduct a formal meta-analysis using the data supplied by 51 of the 185 studies published between 1966 and July 31, 2004, that met the selection criteria. -
Passive Immunization During Pregnancy for CMV
A prospective, non-randomized, non-controlled trial was performed from 1995-2003 at 8 cities in Italy. Pregnant women with primary cytomegalovirus (CMV) infection during, or a few months before, pregnancy were identified by seroconversion, including 148 asymptomatic women, 8 symptomatic women with an acute illness, and 1 asymptomatic woman with fetal abnormalities on ultrasonography. -
Micafungin (Mycamine)
Medical advances in recent decades have resulted in an increased frequency of invasive fungal infections. Specific patient-groups, such as the immunocompromised patients, are especially susceptible to fungal pathogens. -
Updates by Carol A Kemper
Most physicians are aware that Roche withheld the distribution and sales of Tamiflu several weeks ago in order to prevent indiscriminate stock piling of drug badly needed for patients with Influenza A and B this coming winter. -
Pharmacology Watch: Beta-Blockers Therapy for the Treatment of Hypertension
Treatments for Acute Migraine; Statin Therapy for ACS Patients; The Correct Dosing for Onychomycosis; FDA Actions -
Clinical Briefs in Primary Care supplement